Cytokines: interleukin and interferon therapy in dermatology.

Abstract

Cytokines are highly potent biologically active proteins that play an essential role in intercellular communication. They are vital to the mediation and regulation of inflammatory and specific immune reactions as well as to nonimmunological processes. Several cytokines are already used for the treatment of malignant, inflammatory and infectious skin diseases. This in particular includes certain interleukins (ILs) and interferons (IFNs). Whereas some cytokine therapies are already approved and well established, such as IFN-alpha and IL-2 (approved in the USA) for melanoma, others are in the early stages of development and are used in explorative trials (e.g. IL-4 and IL-10 in the treatment of psoriasis). It is likely that some of the new approaches currently under investigation will actually lead to both the registration of new drugs for dermatological treatment, and to supplementation of existing therapeutic options. The aim of this review is to give an overview on the current state of cytokine therapy in dermatology.

• Authors: K Asadullah, W Sterry, U Trefzer
• Journal: Clinical and experimental dermatology (Clin Exp Dermatol) Vol. 27 Issue 7 Pg. 578-84 (Oct 2002) ISSN: 0307-6938 [Print] England
• PMID: 12464153 (Publication Type: Journal Article, Review)

Chemical References

• Antineoplastic Agents
• Antiviral Agents
• Interleukins
• Interferons

Topics

• Antineoplastic Agents (therapeutic use)
• Antiviral Agents (therapeutic use)
• Humans
• Interferons (therapeutic use)
• Interleukins (therapeutic use)
• Skin Diseases (drug therapy)